Steinkraus, Kira C.
Feldmann, Hannah
Hunold, Lisa S.
Graf, Sandra
Dörr-Harim, Colette
Nasir, Nadir
Michalski, Christoph W.
Hüttner, Felix J.
Funding for this research was provided by:
Universitätsklinikum Ulm
Article History
Received: 24 February 2024
Accepted: 26 September 2024
First Online: 10 October 2024
Declarations
:
: The VIP Trial has been approved by the Ethics Committee of the Medical Faculty of Ulm University (reference number 03/22). Written informed consent was obtained from each participant before participation in the study. The purpose of the study was explained to them, and the research team answered any questions the participants might have. They were assured that their participation in this study was completely voluntary.
: Written informed consent was obtained from each participant before participation in the study.
: The authors declare no competing interests.